source name	characteristics[organism]	characteristics[organism part]	characteristics[organism part]	characteristics[brodmann area]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[BRAAK]	characteristics[PMD]	characteristics[biological replicate]	characteristics[APOE]	characteristics[Amyloid]	characteristics[comorbidity]	characteristics[individual]	assay name	technology type	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]		comment[cleavage agent details]	comment[label]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[technical replicate]	factor value[disease]
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_A.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_A.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_A.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_A.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_B.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_B.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_B.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_B.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_C.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_C.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_C.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_01_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_01_C.raw	1	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_A.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_A.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_A.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_A.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_B.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_B.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_B.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_B.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_C.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_C.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_C.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_02_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_02_C.raw	2	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_A.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_A.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_A.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_A.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_B.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_B.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_B.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_B.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_C.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_C.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_C.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_03_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_03_C.raw	3	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_A.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_A.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_A.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_A.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_B.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_B.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_B.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_B.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_C.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_C.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_C.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_04_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_04_C.raw	4	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_A.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_A.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_A.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_A.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_B.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_B.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_B.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_B.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_C.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_C.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_C.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_05_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_05_C.raw	5	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_A.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_A.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_A.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_A.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_B.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_B.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_B.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_B.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_C.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_C.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_C.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_06_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_06_C.raw	6	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_A.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_A.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_A.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_A.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_B.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_B.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_B.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_B.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_C.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_C.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_C.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_07_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_07_C.raw	7	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_A.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_A.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_A.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_A.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_B.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_B.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_B.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_B.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_C.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_C.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_C.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_08_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_08_C.raw	8	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_A.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_A.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_A.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_A.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_B.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_B.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_B.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_B.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_C.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_C.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_C.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_09_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_09_C.raw	9	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_A.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_A.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_A.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_A.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_B.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_B.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_B.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_B.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_C.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_C.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_C.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_10_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_10_C.raw	10	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_A.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_A.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_A.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_A.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_B.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_B.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_B.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_B.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_C.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_C.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_C.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_11_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_11_C.raw	11	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_A.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_A.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_A.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_A.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_B.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_B.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_B.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_B.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_C.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_C.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_C.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_12_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_12_C.raw	12	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_A.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_A.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_A.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_A.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_B.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_B.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_B.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_B.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_C.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_C.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_C.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_13_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_13_C.raw	13	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_A.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_A.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_A.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_A.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_B.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_B.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_B.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_B.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_C.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_C.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_C.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_14_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_14_C.raw	14	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_A.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_A.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_A.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_A.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_B.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_B.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_B.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_B.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_C.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_C.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_C.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_15_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_15_C.raw	15	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_A.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_A.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_A.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_A.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_B.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_B.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_B.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_B.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_C.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_C.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_C.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_16_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_16_C.raw	16	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_A.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_A.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_A.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_A.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_B.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_B.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_B.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_B.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_C.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_C.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_C.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_17_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_17_C.raw	17	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_A.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_A.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_A.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_A.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_B.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_B.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_B.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_B.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_C.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_C.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_C.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_18_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_18_C.raw	18	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_A.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_A.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_A.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_A.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_B.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_B.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_B.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_B.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_C.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_C.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_C.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_19_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_19_C.raw	19	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_A.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_A.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_A.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	1	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_A.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	1	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_B.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_B.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_B.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	2	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_B.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	2	Alzheimer's disease
PXD012203-Sample-1-iTRAQ114	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	67.0 ± 3.0	not available	Female	Non-demented control	adult	1.0 ± 1.0	5.7 ± 0.3	1	32.5 ± 0.5	A	not available	1	1 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_C.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ114	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ115	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	68.0 ± 2.0	not available	Female	Alzheimer's disease	adult	6.0 ± 0.0	5.2 ± 0.0	1	38 ± 5.0	C	not available	1	2 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_C.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ115	10 ppm	0.02 Da	3	Alzheimer's disease
PXD012203-Sample-1-iTRAQ116	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	84.0 ± 3.2	not available	Female	Non-demented control	adult	1.6 ± 0.8	6.3 ± 2.4	1	32.5 ± 0.5	B	not available	1	3 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_C.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ116	10 ppm	0.02 Da	3	Non-demented control
PXD012203-Sample-1-iTRAQ117	Homo sapiens	Brain	Medial frontal gyrus	not available	not available	83.8 ± 3.5	not available	Female	Alzheimer's disease	adult	5.4 ± 4.9	6.0 ± 1.5	1	37 ± 4.9	C	not available	1	4 PXD012203-Sample-1	proteomic profiling by mass spectrometry	PXD012203	140725_Sunil_iTRAQ_AD_20_C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/02/PXD012203//140725_Sunil_iTRAQ_AD_20_C.raw	20	AC=MS:1001911;NT=Q-Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1001251;NT=Trypsin	iTRAQ117	10 ppm	0.02 Da	3	Alzheimer's disease